drugset / Trial / NCT01148147
Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty
RandomizedSingle-groupQuadruple-blindPrevention
Summary
Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of adenosin in elective patients undergoing coronary angioplasty.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adenosine | Small molecule | 120 ug | Other |
| Comparator | Adenosine | Small molecule | 180 ug | Other |